E-LIB Suche - Ergebnisse für: Schwartzberg, LS

1

Rolapitant For Prevention Of Chemotherapy-Induced Nausea An..:

Schwartzberg, LS ; Powers, D ; Arora, S..
Value in Health. 19 (2016) 3 - p. A135-A136 , 2016

Link: https://doi.org/10.1016/..

2

Health State in First (1l) and Second Line (2l) Extensive-D..:

Schwartzberg, LS ; Hussein, M ; Monte, M...
Value in Health. 19 (2016) 3 - p. A159-A160 , 2016

Link: https://doi.org/10.1016/..

3

Design of RESILIENCE: a phase 3 trial comparing capecitabin..:

Baselga, J ; Costa, F ; Gomez, H...
Breast Cancer Research. 13 (2011) S2 - p. , 2011

Link: https://doi.org/10.1186/..

4

PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS ..:

Wielage, RC ; Muehlenbein, CE ; Liepa, AM...
Value in Health. 12 (2009) 3 - p. A39 , 2009

Link: https://doi.org/10.1016/..

5

Incidence of febrile neutropenia during chemotherapy among ..:

Schwartzberg LS ; Lal LS ; Balu S...
https://www.dovepress.com/incidence-of-febrile-neutropenia-during-chemotherapy-among-patients-wi-peer-reviewed-article-CEOR. , 2018

Link: https://doaj.org/article..

6

Evolving role of neurokinin 1-receptor antagonists for chem..:

Navari RM ; Schwartzberg LS
https://www.dovepress.com/evolving-role-of-neurokinin-1-receptor-antagonists-for-chemotherapy-in-peer-reviewed-article-OTT. , 2018

Link: https://doaj.org/article..

7

Prolonged survival in patients with breast cancer and a his..:

Cortés, J ; Rugo, HS ; Awada, A...
https://eprints.whiterose.ac.uk/141473/1/Prolonged%20survival%20in%20patients%20with%20breast%20cancer%20and%20a%20history%20of%20brain%20metastases%3A%20results%20of%20a%20preplanned%20subgroup%20analysis%20from%20the%20randomized%20phase%20III%20BEACON%20trial.pdf. , 2017

Link: https://eprints.whiteros..

8

Clinical effects of prior trastuzumab on combination eribul..:

Puhalla S ; Wilks S ; Brufsky AM...
https://www.dovepress.com/clinical-effects-of-prior-trastuzumab-on-combination-eribulin-mesylate-peer-reviewed-article-BCTT. , 2016

Link: https://doaj.org/article..

9

Design of RESILIENCE: a phase 3 trial comparing capecitabin..:

Baselga, J ; Costa, F ; Gomez, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247045. , 2011

Link: http://www.ncbi.nlm.nih...

10

Design of RESILIENCE: a phase 3 trial comparing capecitabin..:

Baselga, J ; Costa, F ; Gomez, H...
http://breast-cancer-research.com/content/13/S2/O12. , 2011

Link: http://breast-cancer-res..